![Roland Kolbeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 145 140 $ au 31/08/2026
Dr. Roland Kolbeck is a Chief Scientific Officer at Aclaris Therapeutics, Inc. Dr. Kolbeck was previously employed as a Chief Scientific Officer by Spirovant Sciences, Inc. He received his graduate degree from the University of Regensburg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/08/2026 | 23 990 ( 0,02% ) | 145 140 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 28/07/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Spirovant Sciences, Inc.
 Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
University of Regensburg
 University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spirovant Sciences, Inc.
Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
